Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, my priority is the long-term viability of the company and the safety of the 4 million patients. Attempting to bury this data is not only unethical; it is a corporate death sentence. In the age of whistleblowers and data transparency, this will eventually come out.Read the full answer
48-Hour Action Plan: Patient Safety First Critical Reality Check First Your legal team's "6 months" likely refers to a full label revision, not initial safety signal reporting. FDA requires serious unexpected adverse events reported within 15 days (7 days if fatal).Read the full answer